Study finds a promising alternative strategy for combating H. pylori infections

This study is reported by Lizeng Gao's group from the Institute of Biophysics, Chinese Academy of Sciences, Beijing. The growing issue of antibiotic resistance necessitates alternative treatments for the highly prevalent Helicobacter pylori infection. Gao's group has unexpectedly identified hydrogen polysulfide (H₂Sₙ, n≥2) as an active anti-H. pylori compound in garlic, rather than organic polysulfides. Mechanistic studies reveal that H₂Sₙ specifically inactivates H. pylori glucose-6-phosphate dehydrogenase (G6PDH) by disrupting the electron transfer process between glucose-6-phosphate (G6P) and nicotinamide adenine dinucleotide phosphate (NADP⁺). However, garlic derivatives produce low yields of H₂Sₙ, limiting their effectiveness as reliable H₂Sₙ donors for treating H. pylori infection.

To overcome this challenge, Gao's group developed a polysulfide transformation process that converts garlic-derived organosulfur compounds into Fe₃S₄, achieving a 25- to 58-fold increase in H₂Sₙ yield. Furthermore, the development of a chitosan-encapsulated gastric-adaptive H₂Sₙ microreactor (GAPSR) significantly enhanced the treatment outcomes. Under gastric conditions, GAPSR demonstrated 250 times higher efficacy in eradicating H. pylori compared to conventional methods. Remarkably, a single GAPSR treatment achieved a faster eradication of H. pylori than combined antibiotic therapy, while preserving gut microbiota integrity.

These findings highlight a novel mechanism of action driven by polysulfides, presenting a promising alternative strategy for combating H. pylori infections.

Source:
Journal reference:

Wang, X., et al. (2025). Selective G6PDH inactivation for Helicobacter pylori eradication with transformed polysulfide. Science China Life Sciences. doi.org/10.1007/s11427-024-2775-3.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Artificial sweeteners may reduce metformin’s effectiveness in weight and glucose control